Clinical Trial: Clinical Study of Ivonescimab for First-line Treatment of Metastatic Squamous NSCLC Patients
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Non-Small Cell Lung Cancer
Study Type: INTERVENTIONAL
Official Title: A Randomized, Controlled, Multiregional Phase 3 Study of Ivonescimab Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First-line Treatment of Metastatic Squamous Non-
Brief Summary:
This is a Phase 3 Randomized, Controlled, Multiregional Study of Ivonescimab Combined with Chemotherapy Versus Pembrolizumab Combined with Chemotherapy for the First-line Treatment of Metastatic Squamous Non-small Cell Lung Cancer.The primary endpoint is overall survival and key secondary endpoints include progression free survival.response and safety.
Read more